Nuveen, LLC Pliant Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 233,585 shares of PLRX stock, worth $371,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
233,585Holding current value
$371,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLRX
# of Institutions
164Shares Held
62.7MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$9.5 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$7.37 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.3 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$5.08 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $77.4M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...